Search
01/07/2025
Cardiovascular risk assessment in women at high risk for pre-eclampsia in first half of pregnancy
Ullmo, J, Cruz-Lemini, M, Bos-Real, L, Padilla, M, Coma-Barbara, M, Martorell, S, Mora, J, Ordonez-Llanos, J, Llurba, E. Cardiovascular risk assessment in women at high risk for pre-eclampsia in first half of pregnancy. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2025; 66(1)DOI:10.1002/uog.29247. PMID:40471220. IF:6.300(Q1/1D).
01/06/2025
Epigenome-wide association study of pregnancy exposure to green space and placental DNA methylation
Aguilar-Lacasaña, S, Cosin-Tomas, M, Raimbault, B, Gómez-Herrera, L, Sánchez, O, Zanini, MJ, Capdevila, RP, Foraster, M, Gascon, M, Rivas, I, Llurba, E, Gómez-Roig, MD, Sunyer, J, Bustamante, M, Vrijheid, M, Dadvand, P. Epigenome-wide association study of pregnancy exposure to green space and placental DNA methylation. ENVIRONMENTAL RESEARCH. 2025; 274DOI:10.1016/j.envres.2025.121286. PMID:40043929. IF:7.700(Q1/1D).
01/06/2025
Air pollution and fetal brain morphological development: a prospective cohort study
Gómez-Herrera, L, Zhao, Y, Rivas, L, Eixarch, E, Domínguez-Gallardo, C, Galmes, T, Muniesa, M, Zanini, MJ, Domínguez, A, Cirach, M, Nieuwenhuijsen, M, Basagaña, X, Querol, X, Foraster, M, Bustamante, M, Pujol, J, Gascon, M, Llurba, E, Gómez-Roig, MD, Dadvand, P, Sunyer, J. Air pollution and fetal brain morphological development: a prospective cohort study. Lancet Planetary Health. 2025; 9(6)DOI:10.1016/S2542-5196(25)00093-2. PMID:40516539. IF:21.600(Q1/1D).
08/05/2025
The Effect of Probiotics on Preterm Birth Rates in Pregnant Women After a Threatened Preterm Birth Episode (The PROPEV Trial)
del Barco, E, Molano, LAG, Vargas, M, Miserachs, M, Puerto, L, Garrido-Giménez, C, Soler, Z, Muñoz, B, Pratcorona, L, Rimbaut, S, Vidal, M, Dalmau, M, Casellas, A, Carreras, E, Manichanh, C, Goya, M. The Effect of Probiotics on Preterm Birth Rates in Pregnant Women After a Threatened Preterm Birth Episode (The PROPEV Trial). Biomedicines. 2025; 13(5)DOI:10.3390/biomedicines13051141. PMID:40426968. IF:3.900(Q1/3D).
01/04/2025
Current challenges and emerging tools in endometrial cancer diagnosis
Aznar, AL, Canton, R, Loren, G, Carvajal, J, de la Calle, I, Masferrer-Ferragutcasas, C, Serra, F, Bebia, V, Bonaldo, G, Angeles, MA, Cabrera, S, Palomar, N, Vilarmau, C, Marti, M, Rigau, M, Colas, E, Gil-Moreno, A. Current challenges and emerging tools in endometrial cancer diagnosis. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2025; 35(4)DOI:10.1016/j.ijgc.2024.100056. PMID:40011116. IF:4.700(Q1/1D).
01/07/2025
An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study)
Gallego, A, Madariaga, A, Estévez-García, P, Alberti, F, Carbó, A, Palacio, I, Churruca, C, Gálvez, F, Ortega, ME, Murata, P, Manzano, A, Masvidal, M, Martín-Lorente, C, Hernando, B, Lozano, I, Cueva, JF, García-Illescas, D, Gost, E, Mendiola, M, Redondo, A. An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2025; 35(7)DOI:10.1016/j.ijgc.2025.101903. PMID:40382973. IF:4.700(Q1/1D).